Centre issues purchase orders for Covishield & Covaxin

Chennai: The government of India on Monday issued purchase orders to Serum Institute of India and Bharat Biotech for their respective Covid-19 vaccines.

“We have received the (purchase) order from the government of India on Monday afternoon,” a senior SII official said.

The government has already announced that the process of administering the vaccine will start on 16 January.

The SII vaccine developed by Oxford-AstraZeneca was cleared for emergency use along with Bharat Biotech’s indigenous ‘Covaxin’ earlier this month.

The SII has subsequently signed an agreement with the Centre for 11 million [1.1 crore] doses of its coronavirus vaccine. It will be priced at Rs 200 per dose.

According to Serum chief executive Adar Poonawalla, the vaccine would be priced at about Rs 1,000 per dose when it is eventually available in the private market in India.

On the other hand, Covaxin, the one developed by Hyderabad-based Bharat Biotech, will be sold at Rs 295 per dose after a price agreement was arrived at with the government.

The Central Government has asked Bharat Biotech to supply around 55 lakh doses at 12 centres before 14 January, the report said, adding at least 38.5 lakh to be provided in the first stage and 16.5 lakh in the second stage.

The HLL Lifecare Limited, a public sector undertaking, issued the supply order on behalf of the Union Health Ministry.

The first order of 1.1 crore doses will be worth Rs 231 crore, while the total amount, including the commitment for 4.5 crore doses, with the total estimated to reach Rs 1,176 crore at current rates.

 

NT Bureau